Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-01-20 09:38 am Sale | 13G | Asensus Surgical, Inc. ASXC | STATE STREET CORP STT | 817,129 0.35% | -11,886,144 (-93.57%) | View |
| 2022-07-08 4:56 pm Sale | 13G | Asensus Surgical, Inc. ASXC | BlackRock Inc. BLK | 3,684,318 1.6% | -12,109,673 (-76.67%) | View |
| 2022-02-10 12:45 pm Purchase | 13G | Asensus Surgical, Inc. ASXC | STATE STREET CORP STT | 12,703,273 5.42% | 12,703,273 (New Position) | View |
| 2022-02-04 4:12 pm Purchase | 13G | Asensus Surgical, Inc. ASXC | BlackRock Inc. BLK | 15,793,991 6.7% | 2,071,683 (+15.10%) | View |
| 2021-02-16 09:51 am Sale | 13G | Asensus Surgical, Inc. ASXC | CVI Investments Inc. | 0 0% | -8,002,857 (Position Closed) | View |
| 2021-01-28 2:31 pm Sale | 13G | Asensus Surgical, Inc. ASXC | Empery Asset Management LP | 6,450,012 4.99% | -2,121,416 (-24.75%) | View |
| 2021-01-05 11:03 am Purchase | 13G | Asensus Surgical, Inc. ASXC | SABBY MANAGEMENT LLC | 4,985,523 11% | 607,106 (+13.87%) | View |
| 2020-07-07 11:30 am Purchase | 13G | TransEnterix Inc. TRXC | CVI Investments Inc. | 8,002,857 8% | 8,002,857 (New Position) | View |
| 2020-07-07 10:44 am Purchase | 13G | Asensus Surgical, Inc. ASXC | Empery Asset Management LP | 8,571,428 9.1% | 8,571,428 (New Position) | View |
| 2020-03-20 4:30 pm Sale | 13D | Asensus Surgical, Inc. ASXC | SOFAR S.p.A | 1,482,008 3.2% | -17,784,090 (-92.31%) | View |
| 2020-03-06 11:47 am Purchase | 13G | Asensus Surgical, Inc. ASXC | SABBY MANAGEMENT LLC | 4,378,417 11% | 4,378,417 (New Position) | View |
| 2020-02-21 5:27 pm Purchase | 13G | Asensus Surgical, Inc. ASXC | Big Flower Trust | 1,629,431 7.9% | 1,629,431 (New Position) | View |
| 2020-02-10 2:19 pm Sale | 13G | Asensus Surgical, Inc. ASXC | BlackRock Inc. BLK | 976,927 4.7% | -30,379 (-3.02%) | View |
| 2020-02-06 09:10 am Sale | 13G | Asensus Surgical, Inc. ASXC | BlackRock Inc. BLK | 1,007,306 5.1% | -12,715,002 (-92.66%) | View |
| 2019-03-01 5:06 pm Unchanged | 13D | TRANSENTERIX INC. TRXC | SOFAR S.p.A | 19,266,098 8.9% | 0 (Unchanged) | View |
| 2019-03-01 5:04 pm Sale | 13D | TRANSENTERIX INC. TRXC | SYNERGY LIFE SCIENCE PARTNERS L P | 2,301,792 1% | -25,833,349 (-91.82%) | View |
| 2019-02-07 6:09 pm Purchase | 13G | TRANSENTERIX INC. TRXC | BlackRock Inc. BLK | 13,722,308 6.3% | 10,270,463 (+297.54%) | View |
| 2018-06-05 5:27 pm Sale | 13D | TransEnterix Inc. TRXC | AISLING CAPITAL III LP | 6,389,352 3.1% | -5,101,479 (-44.40%) | View |